InvestorsHub Logo
Followers 165
Posts 19981
Boards Moderated 2
Alias Born 12/09/2004

Re: frrol post# 429268

Monday, 09/04/2023 5:00:13 PM

Monday, September 04, 2023 5:00:13 PM

Post# of 466127
AFAIK there were no OR endpoints.

There was OR given in the presentation in what appeared to me to be an illustrative manner to show improvement over baseline.

What evidence do you have to support you statement that the company is struggling with getting clear dose sub-grouping?
Titration by its nature leads to a data point spread. Since titration is not uncommon there must be ways of statistically dealing with it.

Biology is messy.

I can explain it to you, but I can't understand it for you.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News